Please assess the completion status of the following clinical trial:

Trial Title: Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Received treatment for asthma in the year prior to study entry~* Received at least one respiratory medication at a Kaiser Permanente Northwest (KPNW) or Kaiser Permanente Hawaii (KPH) outpatient pharmacy in the year prior to study entry~* Continuous Kaiser Permanente membership from the year prior to study entry through study entry~* Willing to participate in the study~Exclusion Criteria:~* Excluded from primary analyses if fewer than three months of follow-up

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Automated Phone-Based Refill Reminders (Type: EXPERIMENTAL): Intervention Arm: Participants randomly assigned to this study arm may receive up to 8 automated phone calls from the BREATH EASY Medication Reminder Program over the course of the 19 month intervention period.
- Usual Care (Type: NO_INTERVENTION): Usual Care: Participants randomly assigned to this arm received the same introductory letter as those in the intervention arm, giving them the opportunity to opt out, but were subsequently selected to be in the usual care study arm, and therefore, receive no intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).